Search for: "Watson Laboratories" Results 121 - 140 of 249
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2011, 6:50 pm by Editors
Check out these featured jobs courtesy of GoInhouse.com: Counsel – Confidential, Bergen County, NJ Associate General Counsel – eHealthInsurance, Mountain View, CA Attorney – Pacific Northwest National Laboratory, Richland, WA Counsel – Towers Watson, Washington, DC (New York, Philadelphia, Arlingto) Counsel – Towers Watson, New York, NY (Philadelphia, Arlingto) Compliance Counsel – Confidential, New York, NY (Midtown Manhattan)… [read post]
19 Jan 2011, 2:44 pm by Phil
The case goes back to $398 million that Bayer allegedly paid Watson Pharmaceuticals Inc., Barr Laboratories Inc. and others supposedly in exchange for the companies not marketing lower-cost generic versions of the antibiotic Cipro. [read post]
1 Dec 2011, 2:02 pm by Tom Lamb
(NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz(R) oral contraceptive product. [read post]
25 Oct 2007, 2:09 pm
Nobel Laureate & DNA Discoverer James Watson Forced Out After Racist Comments:  "[T]he Cold Spring Harbor Laboratory Board of Trustees decided to suspend the administrative responsibilities of Chancellor James D. [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
The FTC’s complaint alleges that Endo engaged in a pay for delay scheme by paying the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
15 Apr 2013, 7:16 am by Rahul Bhagnari, ACLU
Other laboratories cannot provide second opinions, and they cannot include the BRCA genes when offering testing of the multiple genes that are now associated with breast and ovarian cancer risk. [read post]
8 Jun 2010, 8:14 am by Brian Wm. Higgins
Watson Laboratories, Inc., No. 1:2010cv01323 (filed May 24, 2010); this Hatch-Waxman patent infringement lawsuit was brought by Genzyme after Watson sought Food and Drug Administration (FDA) approval to market in the US a generic version of the company's Renvela(R) drug product (sevelamer carbonate). [read post]
15 Jul 2011, 11:32 pm by Apeng
(IP Watch) (KEI) (Spicy IP) (GenericsWeb) Mucinex (Guaifenesin) – US: File history disclaimer dooms Reckitt Benckiser at CAFC: Reckitt Benckiser v Watson Laboratories / ?????? [read post]
15 Jul 2011, 11:32 pm by Apeng
(IP Watch) (KEI) (Spicy IP) (GenericsWeb) Mucinex (Guaifenesin) – US: File history disclaimer dooms Reckitt Benckiser at CAFC: Reckitt Benckiser v Watson Laboratories / ?????? [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
26 Mar 2010, 2:14 am by Andrew Lavoott Bluestone
Cold Spring, the former home of DNA researcher James Watson, is well known for genetics research. [read post]
26 Mar 2010, 2:14 am by Andrew Lavoott Bluestone
Cold Spring, the former home of DNA researcher James Watson, is well known for genetics research. [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs)   Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
26 May 2007, 11:26 pm
Now, Barr Laboratories, based in Woodcliff Lake, is seek ing to invalidate Ambien CR's patent as obvious.Calvert Crary, a Connecticut lawyer who published a paper on the case, said the ruling means the patents on medicines based on standard laboratory formulation techniques, or "tweaks," may be vulnerable to challenge. [read post]
25 Apr 2012, 9:05 am by FDABlog HPM
  The owners of the three approved ANDAs for generic oral vancomycin—Akorn, Incorporated (“Akorn”), Watson Laboratories, Inc. [read post]
27 Jun 2010, 10:37 pm by Carey, Danis & Lowe
It targets the companies Pliva Pharmaceuticals, Barr Laboratories, Teva Pharmaceuticals and Watson Pharmaceuticals — all are generic manufacturers of Reglan. [read post]